Literature DB >> 35194348

Emerging Trend to Have Locally Advanced Malignancies at Initial Presentation: Ignorance, Self-Neglect, or Pandemic Anxiety?

Jasb Jayasundara1.   

Abstract

Entities:  

Year:  2022        PMID: 35194348      PMCID: PMC8832076          DOI: 10.1007/s12262-022-03326-2

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


× No keyword cloud information.
Dear Editor in Chief, Malignancies are the second commonest cause for in-hospital mortality and one of the leading causes for hospitalization in Sri Lanka [1]. About 29,000 new cancer patients have been reported in 2015 according to the National Cancer Control Program data [2]. Breast and thyroid malignancies have been the commonest cancers among females, while oral cavity and lung cancers have been the commonest among males [2]. It has been studied that a higher percentage of female breast cancers in Sri Lanka to be diagnosed at an advanced tumor, nodal and metastasis stage according to a single tertiary care center pre-pandemic registry data [3]. This fact may be common to almost all other solid organ malignancies in Sri Lanka. Further, presentation delay with advanced cancers at initial clinical review has been a concern in neighboring India over past couple of decades [4-6]. In general, such delayed and advanced cancer at presentation negatively affects the prognosis. Unavailability of screening programs for common malignancies in Sri Lanka appears to be the foremost reason for such delayed cancer presentation, in addition to lack of disease awareness among people, self-neglect, and fear of stigmatization over cancers. Studies from the sub-continent have shared similar reasons [4, 5]. Covid-19 anxiety appears to be the newest addition to this list. These concerns seem to be common not only to India and Sri Lanka but also to entire South Asia. Since the declaration of the current pandemic by the World Health Organization in early 2020, Sri Lanka has experienced four waves of Covid-19 surge. As a result, elective medical and surgical care services at both hospital and community level have been very much negatively affected. Further, the stigma and discrimination experienced by many Covid-19 patients in the society, work place and at healthcare facilities have worsened pandemic anxiety, and patients have been reluctant to seek medical attention [7]. Within such altered status quo, probably contributed by many other socioeconomic factors including pandemic fear, I have recently encountered many cases of locally advanced malignancies presenting late to healthcare facilities. Fungating breast cancers, ulcerating head and neck cancers/melanomas, and manhood destructing penile cancers which were “diseases of the past” have been re-emerging at a rural District General Hospital in Nuwaraeliya over last 8–10 months. These collateral damages of the pandemic may be a common problem still remaining unnoticed not only in other parts of Sri Lanka but also in other developing countries. The restrictions and altered practices carried out during the pandemic have been obvious and universal. There have been regional, geographical, and individual variations on health policy and threat perception at the height of the pandemic, and we may be experiencing the negative aftermath of such altered behaviors at the moment. Despite the global trend to detect pre-symptomatic malignancies to achieve optimal outcome, these patients have failed to reach a healthcare provider until they have developed organ destructing, grossly disfiguring, ulcerative malignancies during the pandemic. Reasons for delayed presentation may be multifactorial. As it has been further complicated by the pandemic anxiety and fatigue, it is important for clinicians, preventive medicine experts, and policy makers to be vigilant over these developments to control the collateral “malignant” damages of the pandemic at the verge of another global Covid-19 wave with the Omicron variant.
  5 in total

1.  Delay in presentation of oral cancer: a multifactor analytical study.

Authors:  S Kumar; R F Heller; U Pandey; V Tewari; N Bala; K T Oanh
Journal:  Natl Med J India       Date:  2001 Jan-Feb       Impact factor: 0.537

2.  An investigation of delay in treatment of breast cancer.

Authors:  H S Shukla; S Kumar; K Avasthi; Y P Naithani
Journal:  Indian J Med Res       Date:  1981-05       Impact factor: 2.375

3.  Delays in Diagnosis and Treatment of Breast Cancer and the Pathways of Care: A Mixed Methods Study from a Tertiary Cancer Centre in North East India.

Authors:  Arvind Kumar; Srabana Misra Bhagabaty; Jaya Prasad Tripathy; Kalaiselvi Selvaraj; Joydeep Purkayastha; Ravikant Singh
Journal:  Asian Pac J Cancer Prev       Date:  2019-12-01

4.  Demographic, tumour, and treatment characteristics of female patients with breast cancer in Sri Lanka; results from a hospital-based cancer registry.

Authors:  Don Thiwanka Wijeratne; Sanjeeva Gunasekera; Christopher M Booth; Hasitha Promod; Matthew Jalink; Umesh Jayarajah; Sanjeewa Seneviratne
Journal:  BMC Cancer       Date:  2021-11-03       Impact factor: 4.430

5.  'Why are you not dead yet?' - dimensions and the main driving forces of stigma and discrimination among COVID-19 patients in Sri Lanka.

Authors:  S Jayakody; S A Hewage; N D Wickramasinghe; R A P Piyumanthi; A Wijewickrama; N S Gunewardena; S Prathapan; C Arambepola
Journal:  Public Health       Date:  2021-07-10       Impact factor: 2.427

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.